Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-14 Purchase |
2024-11-15 2:43 pm |
Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO |
11,706 | $0.85 | $9,950 | 11,706 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
19,608 | $10.56 | $207,091 | 161,994 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
15,548 | $10.85 | $168,631 | 15,571 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
73,127 | $10.91 | $798,023 | 104,758 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
20,694 | $12.69 | $262,700 | 94,267 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-20 6:00 pm |
N/A 2028-02-18 |
Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO |
1,255,525 | $0 | 1,255,525 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:01 pm |
N/A 2027-05-31 |
Assertio Holdings Inc. | ASRT | O'Grady Brendan P. CEO |
2,300,000 | $0 | 2,300,000 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
18,905 | $0 | 161,994 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
109,315 | $0 | 161,994 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
1,166 | $0 | 15,571 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
24,934 | $0 | 104,758 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-11 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
16,120 | $0 | 94,267 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
67,852 | $0 | 94,267 (Direct) |
View |